sales@businessmarketinsights.com   UK: +442030260021  , US: +16467917070  , Toll Free: 1800 121 6455
Biotechnology Asia Pacific Stem Cell Therapy Market...

Asia Pacific Stem Cell Therapy Market Forecast to 2028 - COVID-19 Impact and Regional Analysis by Type (Adult Stem Cell Therapy, Embryonic Stem Cell Therapy, Induced Pluripotent Stem Cell Therapy, and Other Stem Cell Therapy), Treatment (Allogeneic and Autologous), Application (Musculoskeletal, Dermatology, Cardiology, Drug Discovery & Development, and Other Applications), and End User (Hospitals & Specialty Clinics and Academic & Research Institutes)

BMIRE00028465 | Pages: 141 | Biotechnology | May 2023 | Type: Regional | Status: Published

The Asia Pacific stem cell therapy market was valued at US$ 403.94 million in 2022 and is projected to reach US$ 1,180.20 million by 2028; it is expected to grow at a CAGR of 19.6% from 2022 to 2028.

Use of Induced Pluripotent Stem Cells in Regenerative Medicines is Driving the Asia Pacific Stem Cell Therapy Market

Per the Frontiers Media S.A. 2023 report, progress in the field of induced pluripotent stem cells (iPSCs) has opened a new gateway for research in therapeutics. iPSCs are mainly intended for research and clinical studies such as disease modeling, regenerative medicine, and drug discovery/drug cytotoxicity studies. For example, iPSCs can be used to convert differentiated somatic cells to multipotent stem cells to generate different cell types of adult tissues. Thus, iPSCs have shown promising results in regenerative medicine, particularly for replacing diseased or injured cells. iPSCs are widely used to regenerate tissue-specific cells for transplantation in patients for treating injuries and degenerative diseases. Studies such as drug discovery involving screening of small molecules and toxicity testing for safety assessment have been successfully disclosed positive iPSCs-based results. The aforementioned factors are expected to offer lucrative growth opportunities to companies in the stem cell therapy market in the coming years.

Asia Pacific Stem Cell Therapy Market Overview   

Asia Pacific stem cell therapy market is analyzed based on the five major countries such as China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. The Asia Pacific region is expected to be the fastest-growing region among all other regions. The growth of the market in the Asia Pacific region is expected to grow at a faster pace owing to factors such as increasing need for superior treatment solutions, favorable regulatory scenarios, increasing focus on research and development activities, and growing awareness regarding benefits offered by stem cell therapy. Additionally, developing healthcare infrastructure and increasing investments in order to boost the research activities are projected to drive the Asia Pacific stem cell therapy market during the forecast period.

Asia Pacific Stem Cell Therapy Market Revenue and Forecast to 2028 (US$ Million)

Get more information on this report :

Asia Pacific Stem Cell Therapy Market Segmentation

The Asia Pacific stem cell therapy market is segmented into type, treatment, application, end user, and country.

The Asia Pacific stem cell therapy market, by type, is segmented into adult stem cell therapy, induced pluripotent stem cell therapy, embryonic stem cell therapy, and other stem cell therapy. The adult stem cell therapy segment held the largest market share in 2022. 

Based on treatment, the Asia Pacific stem cell therapy market is bifurcated into allogeneic and autologous. The allogenic segment held the largest share of the market in 2022.

Based on application, the Asia Pacific stem cell therapy market is divided into musculoskeletal, dermatology, cardiology, drug discovery and development, other applications. The musculoskeletal segment held the largest share of the market in 2022.  

The Asia Pacific stem cell therapy market, by end user, is segmented into academic & research institutes and hospitals & clinics. The academic & research institutes segment held the largest share of the market in 2022.

Based on country, the Asia Pacific stem cell therapy market is segmented into Japan, China, India, South Korea, Australia, and the Rest of Asia Pacific. Germany dominated the market in 2022.

MEDIPOST; Mesoblast Limited; TiGenix NV; JCR Pharmaceuticals Co. Ltd.; and NuVasive Inc are the leading companies operating in the Asia Pacific stem cell therapy market.

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        Asia Pacific Stem Cell Therapy Market – By Type

1.3.2        Asia Pacific Stem Cell Therapy Market – By Treatment

1.3.3        Asia Pacific Stem Cell Therapy Market – By Application

1.3.4        Asia Pacific Stem Cell Therapy Market – By End User

1.3.5        Asia Pacific Stem Cell Therapy Market – By Country

2.           Asia Pacific Stem Cell Therapy Market – Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Asia Pacific Stem Cell Therapy Market– Market Landscape

4.1         Overview

4.2         Asia Pacific PEST Analysis

4.3         Experts Opinion

5.           Asia Pacific Stem Cell Therapy Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Increasing Research Activities Related to Stem Cell Therapy for Effective Disease Management

5.1.2        Growing Prevalence of Cancer

5.2         Market Restraints

5.2.1        Availability of Illegal and Unapproved Products, and High Cost of Approved Treatments

5.3         Market Opportunities

5.3.1        Use of Induced Pluripotent Stem Cells in Regenerative Medicines

5.4         Future Trends

5.4.1        Research Activities and Product Innovations

5.5         Impact Analysis

6.           Stem Cell Therapy Market – Asia Pacific Analysis

6.1         Asia Pacific Stem Cell Therapy Market Revenue Forecast and Analysis

7.           Asia Pacific Stem Cell Therapy Market – Revenue and Forecast to 2028 – by Type

7.1         Overview

7.2         Asia Pacific Stem Cell Therapy Market Revenue Share, by Type 2021 & 2028 (%)

7.3         Adult Stem Cell Therapy

7.3.1        Overview

7.3.2        Adult Stem Cell Therapy: Asia Pacific Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)

7.3.3        Hematopoietic Stem Cell Therapy

7.3.3.1          Overview

7.3.3.2          Hematopoietic Stem Cell Therapy: Asia Pacific Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)

7.3.4        Umbilical Cord Stem Cell Therapy

7.3.4.1          Overview

7.3.4.2          Umbilical Cord Stem Cell Therapy: Asia Pacific Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)

7.3.5        Neuronal Stem Cell Therapy

7.3.5.1          Overview

7.3.5.2          Neuronal Stem Cell Therapy: Asia Pacific Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)

7.3.6        Mesenchymal Stem Cell

7.3.6.1          Overview

7.3.6.2          Mesenchymal Stem Cell: Asia Pacific Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)

7.4         Embryonic Stem Cell Therapy

7.4.1        Overview

7.4.2        Embryonic Stem Cell Therapy: Asia Pacific Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)

7.5         Induced Pluripotent Stem Cell Therapy

7.5.1        Overview

7.5.2        Induced Pluripotent Stem Cell Therapy: Asia Pacific Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)

7.6         Other Stem Cell Therapy

7.6.1        Overview

7.6.2        Other Stem Cell Therapy: Asia Pacific Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)

8.           Asia Pacific Stem Cell Therapy Market Analysis and Forecasts to 2028 – by Treatment

8.1         Overview

8.2         Asia Pacific Stem Cell Therapy Market, by Treatment 2021 & 2028 (%)

8.3         Allogeneic

8.3.1        Overview

8.3.2        Allogeneic: Asia Pacific Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)

8.4         Autologous

8.4.1        Overview

8.4.2        Autologous: Asia Pacific Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)

9.           Asia Pacific Stem Cell Therapy Market Analysis and Forecasts to 2028 – by Application

9.1         Overview

9.2         Asia Pacific Stem Cell Therapy Market, by Application 2021 & 2028 (%)

9.3         Musculoskeletal

9.3.1        Overview

9.3.2        Musculoskeletal: Asia Pacific Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)

9.4         Dermatology

9.4.1        Overview

9.4.2        Dermatology: Asia Pacific Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)

9.5         Cardiology

9.5.1        Overview

9.5.2        Cardiology: Asia Pacific Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)

9.6         Drug Discovery and Development

9.6.1        Overview

9.6.2        Drug Discovery and Development: Asia Pacific Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)

9.7         Other Applications

9.7.1        Overview

9.7.2        Other Applications: Asia Pacific Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)

10.        Asia Pacific Stem Cell Therapy Market – Revenue and Forecast to 2028 – by End User

10.1      Overview

10.2      Asia Pacific Stem Cell Therapy Market Revenue Share, by End User 2021 & 2028 (%)

10.3      Academic & Research Institutes

10.3.1     Overview

10.3.2     Academic & Research Institutes: Asia Pacific Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)

10.4      Hospitals & Specialty Clinics

10.4.1     Overview

10.4.2     Hospitals & Specialty Clinics: Asia Pacific Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)

11.        Asia Pacific Stem Cell Therapy Market – Revenue and Forecast to 2028 – Country Analysis

11.1      Overview

11.1.1     Asia Pacific: Stem Cell Therapy Market, by Country, 2021 & 2028 (%)

11.1.1.1       China: Stem Cell Therapy Market – Revenue and Forecast to 2028 (USD Million)

11.1.1.1.1       China: Stem Cell Therapy Market – Revenue and Forecast to 2028 (USD Million)

11.1.1.1.2       China: Stem Cell Therapy Market, by Type, 2019-2028 (USD Million)

11.1.1.1.2.1     China: Stem Cell Therapy Market, by Adult Stem Cell Therapy, 2019-2028 (USD Million)

11.1.1.1.3       China: Stem Cell Therapy Market, by Treatment, 2019-2028 (USD Million)

11.1.1.1.4       China: Stem Cell Therapy Market, by Application, 2019-2028 (USD Million)

11.1.1.1.5       China: Stem Cell Therapy Market, by End User , 2019-2028 (USD Million)

11.1.1.2       Japan: Stem Cell Therapy Market – Revenue and Forecast to 2028 (USD Million)

11.1.1.2.1       Japan: Stem Cell Therapy Market – Revenue and Forecast to 2028 (USD Million)

11.1.1.2.2       Japan: Stem Cell Therapy Market, by Type, 2019-2028 (USD Million)

11.1.1.2.2.1     Japan: Stem Cell Therapy Market, by Adult Stem Cell Therapy, 2019-2028 (USD Million)

11.1.1.2.3       Japan: Stem Cell Therapy Market, by Treatment, 2019-2028 (USD Million)

11.1.1.2.4       Japan: Stem Cell Therapy Market, by Application, 2019-2028 (USD Million)

11.1.1.2.5       Japan: Stem Cell Therapy Market, by End User , 2019-2028 (USD Million)

11.1.1.3       India: Stem Cell Therapy Market – Revenue and Forecast to 2028 (USD Million)

11.1.1.3.1       India: Stem Cell Therapy Market – Revenue and Forecast to 2028 (USD Million)

11.1.1.3.2       India: Stem Cell Therapy Market, by Type, 2019-2028 (USD Million)

11.1.1.3.2.1     India: Stem Cell Therapy Market, by Adult Stem Cell Therapy, 2019-2028 (USD Million)

11.1.1.3.3       India: Stem Cell Therapy Market, by Treatment, 2019-2028 (USD Million)

11.1.1.3.4       India: Stem Cell Therapy Market, by Application, 2019-2028 (USD Million)

11.1.1.3.5       India: Stem Cell Therapy Market, by End User , 2019-2028 (USD Million)

11.1.1.4       South Korea: Stem Cell Therapy Market – Revenue and Forecast to 2028 (USD Million)

11.1.1.4.1       South Korea: Stem Cell Therapy Market – Revenue and Forecast to 2028 (USD Million)

11.1.1.4.2       South Korea: Stem Cell Therapy Market, by Type, 2019-2028 (USD Million)

11.1.1.4.2.1     South Korea: Stem Cell Therapy Market, by Adult Stem Cell Therapy, 2019-2028 (USD Million)

11.1.1.4.3       South Korea: Stem Cell Therapy Market, by Treatment, 2019-2028 (USD Million)

11.1.1.4.4       South Korea: Stem Cell Therapy Market, by Application, 2019-2028 (USD Million)

11.1.1.4.5       South Korea: Stem Cell Therapy Market, by End User , 2019-2028 (USD Million)

11.1.1.5       Australia: Stem Cell Therapy Market – Revenue and Forecast to 2028 (USD Million)

11.1.1.5.1       Australia: Stem Cell Therapy Market – Revenue and Forecast to 2028 (USD Million)

11.1.1.5.2       Australia: Stem Cell Therapy Market, by Type, 2019-2028 (USD Million)

11.1.1.5.2.1     Australia: Stem Cell Therapy Market, by Adult Stem Cell Therapy, 2019-2028 (USD Million)

11.1.1.5.3       Australia: Stem Cell Therapy Market, by Treatment, 2019-2028 (USD Million)

11.1.1.5.4       Australia: Stem Cell Therapy Market, by Application, 2019-2028 (USD Million)

11.1.1.5.5       Australia: Stem Cell Therapy Market, by End User, 2019-2028 (USD Million)

11.1.1.6       Rest of Asia Pacific: Stem Cell Therapy Market – Revenue and Forecast to 2028 (USD Million)

11.1.1.6.1       Rest of Asia Pacific: Stem Cell Therapy Market – Revenue and Forecast to 2028 (USD Million)

11.1.1.6.2       Rest of Asia Pacific: Stem Cell Therapy Market, by Type, 2019-2028 (USD Million)

11.1.1.6.2.1     Rest of Asia Pacific: Stem Cell Therapy Market, by Adult Stem Cell Therapy, 2019-2028 (USD Million)

11.1.1.6.3       Rest of Asia Pacific: Stem Cell Therapy Market, by Treatment, 2019-2028 (USD Million)

11.1.1.6.4       Rest of Asia Pacific: Stem Cell Therapy Market, by Application, 2019-2028 (USD Million)

11.1.1.6.5       Rest of Asia Pacific: Stem Cell Therapy Market, by End User , 2019-2028 (USD Million)

12.        Stem Cell Therapy Market–Industry Landscape

12.1      Overview

12.2      Growth Strategies in the Stem Cell Therapy Market (%)

12.3      Organic Developments

12.3.1     Overview

12.4      Inorganic Developments

12.4.1     Overview

13.        Company Profiles

13.1      MEDIPOST

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2      Mesoblast Limited

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3      TiGenix NV

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4      NuVasive Inc

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5      JCR Pharmaceuticals Co. Ltd.

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

14.        Appendix

14.1      About The Insight Partners

14.2      Glossary of Terms

 

 

LIST OF TABLES

Table 1.             Cost Expenditure of Stem Cell Injection

Table 2.             China Stem Cell Therapy Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 3.             China Stem Cell Therapy Market, by Adult Stem Cell Therapy – Revenue and Forecast to 2028 (USD Million)

Table 4.             China Stem Cell Therapy Market, by Treatment – Revenue and Forecast to 2028 (USD Million)

Table 5.             China Stem Cell Therapy Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 6.             China Stem Cell Therapy Market, by End-User – Revenue and Forecast to 2028 (USD Million)

Table 7.             Japan Stem Cell Therapy Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 8.             Japan Stem Cell Therapy Market, by Adult Stem Cell Therapy – Revenue and Forecast to 2028 (USD Million)

Table 9.             Japan Stem Cell Therapy Market, by Treatment – Revenue and Forecast to 2028 (USD Million)

Table 10.          Japan Stem Cell Therapy Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 11.          Japan Stem Cell Therapy Market, by End-User – Revenue and Forecast to 2028 (USD Million)

Table 12.          India Stem Cell Therapy Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 13.          India Stem Cell Therapy Market, by Adult Stem Cell Therapy – Revenue and Forecast to 2028 (USD Million)

Table 14.          India Stem Cell Therapy Market, by Treatment – Revenue and Forecast to 2028 (USD Million)

Table 15.          India Stem Cell Therapy Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 16.          India Stem Cell Therapy Market, by End-User – Revenue and Forecast to 2028 (USD Million)

Table 17.          South Korea Stem Cell Therapy Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 18.          South Korea Stem Cell Therapy Market, by Adult Stem Cell Therapy – Revenue and Forecast to 2028 (USD Million)

Table 19.          South Korea Stem Cell Therapy Market, by Treatment – Revenue and Forecast to 2028 (USD Million)

Table 20.          South Korea Stem Cell Therapy Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 21.          South Korea Stem Cell Therapy Market, by End-User – Revenue and Forecast to 2028 (USD Million)

Table 22.          Australia Stem Cell Therapy Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 23.          Australia Stem Cell Therapy Market, by Adult Stem Cell Therapy – Revenue and Forecast to 2028 (USD Million)

Table 24.          Australia Stem Cell Therapy Market, by Treatment – Revenue and Forecast to 2028 (USD Million)

Table 25.          Australia Stem Cell Therapy Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 26.          Australia Stem Cell Therapy Market, by End-User – Revenue and Forecast to 2028 (USD Million)

Table 27.          Rest of Asia Pacific Stem Cell Therapy Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 28.          Rest of Asia Pacific Stem Cell Therapy Market, by Adult Stem Cell Therapy – Revenue and Forecast to 2028 (USD Million)

Table 29.          Rest of Asia Pacific Stem Cell Therapy Market, by Treatment – Revenue and Forecast to 2028 (USD Million)

Table 30.          Rest of Asia Pacific Stem Cell Therapy Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 31.          Rest of Asia Pacific Stem Cell Therapy Market, by End-User – Revenue and Forecast to 2028 (USD Million)

Table 32.          Organic Developments in the Stem Cell Therapy Market

Table 33.          Inorganic Developments in the Stem Cell Therapy Market

Table 34.          Glossary of Terms

 

 

LIST OF FIGURES

Figure 1.           Asia Pacific Stem Cell Therapy Market Segmentation

Figure 2.           Asia Pacific Stem Cell Therapy Segmentation, By Country

Figure 3.           Asia Pacific Stem Cell Therapy Market Overview

Figure 4.           Adult Stem Cell Therapy Segment Held Largest Share of Type Segment in Asia Pacific Stem Cell Therapy Market

Figure 5.           Japan Is Expected to Show Remarkable Growth During the Forecast Period

Figure 7.           Asia Pacific PEST Analysis

Figure 8.           Experts Opinion

Figure 9.           Asia Pacific Stem Cell Therapy Market Impact Analysis of Drivers and Restraints

Figure 10.        Asia Pacific Stem Cell Therapy Market – Revenue Forecast and Analysis – 2020- 2028

Figure 11.        Asia Pacific Stem Cell Therapy Market Revenue Share, by Type 2021 & 2028 (%)

Figure 12.        Adult Stem Cell Therapy: Asia Pacific Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13.        Hematopoietic Stem Cell Therapy: Asia Pacific Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14.        Umbilical Cord Stem Cell Therapy: Asia Pacific Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15.        Neuronal Stem Cell Therapy: Asia Pacific Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16.        Mesenchymal Stem Cell: Asia Pacific Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17.        Embryonic Stem Cell Therapy: Asia Pacific Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 18.        Induced Pluripotent Stem Cell Therapy: Asia Pacific Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19.        Other Stem Cell Therapy: Asia Pacific Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20.        Asia Pacific Stem Cell Therapy Market, by Treatment 2021 & 2028 (%)

Figure 21.        Allogeneic: Asia Pacific Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22.        Autologous: Asia Pacific Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 23.        Asia Pacific Stem Cell Therapy Market, by Application 2021 & 2028 (%)

Figure 24.        Musculoskeletal: Asia Pacific Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25.        Dermatology: Asia Pacific Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26.        Cardiology: Asia Pacific Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27.        Drug Discovery and Development: Asia Pacific Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 28.        Other Applications: Asia Pacific Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 29.        Asia Pacific Stem Cell Therapy Market Revenue Share, by End User 2021 & 2028 (%)

Figure 30.        Academic & Research Institutes: Asia Pacific Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 31.        Hospitals & Specialty Clinics: Asia Pacific Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 32.        Asia Pacific: Stem Cell Therapy Market, by Key Country – Revenue (2021) (USD Million)

Figure 33.        China: Stem Cell Therapy Market – Revenue and Forecast to 2028 (USD Million)

Figure 34.        Japan: Stem Cell Therapy Market – Revenue and Forecast to 2028 (USD Million)

Figure 35.        India: Stem Cell Therapy Market – Revenue and Forecast to 2028 (USD Million)

Figure 36.        South Korea: Stem Cell Therapy Market – Revenue and Forecast to 2028 (USD Million)

Figure 37.        Australia: Stem Cell Therapy Market – Revenue and Forecast to 2028 (USD Million)

Figure 38.        Rest of Asia Pacific: Stem Cell Therapy Market – Revenue and Forecast to 2028 (USD Million)

Figure 39.        Growth Strategies in the Stem Cell Therapy Market (%)

 

  1. MEDIPOST
  2. Mesoblast Limited
  3. TiGenix NV
  4. NuVasive Inc
  5. JCR Pharmaceuticals Co. Ltd.
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Asia Pacific stem cell therapy market
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific stem cell therapy market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the stem cell therapy market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports
Report Name Published Date
Asia Pacific Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software an.. May 2022
Asia Pacific Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Elec.. May 2022
Asia Pacific Ground Engaging Tools Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Application (Excavators, Loaders, Bulldozers, an.. May 2022
Purchase Options
Single User License
$3000
$2400
Site License
$4000
$3200
Enterprise License
$5000
$4000
GET FREE SAMPLE PDF
Inquire before Buying Inquire for Discount
Subscription Member Price: FREE
Get Subscription